During 3Q, 1,429 VC investors participated in at least one financing round, investing a combined $51.2 billion globally. Of the 1,400+ completed deals during the quarter, 42 generated a valuation of at least $1 billion, with four surpassing the $10 billion valuation mark. The top sectors of focus this quarter: software (40% of deal flow), commercial services (12%), biotech (7%) and healthcare devices & supplies (4%). Of the investors, 287 manage between $100 million and $500 million of assets, while another 158 manage $1 billion or more.
Top VC investors during 3Q, along with their deal counts: